FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992307218> ?p ?o ?g. }

• W1992307218 endingPage "439" @default.
• W1992307218 startingPage "431" @default.
• W1992307218 abstract "Dry eye (DE) is a common ocular surface disease, particularly among women and the elderly, with chronic symptoms of eye irritation and, in severe cases, blurred vision. Several studies have shown that there is an inflammatory component in DE, although the pathogenesis is not thoroughly understood. Resolvin E1 (RvE1; RX-10001) is an endogenous mediator derived from the omega-3 polyunsaturated fatty acid eicosapentaenoic acid and is involved in inflammation resolution and tissue protection. Here we investigated the role of RvE1 in a DE mouse model.Thirteen- to 14-week-old female BALB/C mice were exposed to desiccating conditions. One week after DE exposure, animals were treated topically with drug or vehicle 4 times per day for an additional week. Controls were nontreated animals placed in a normal environment. Schirmer's test was performed before treatment initiation and at days 2 and 4 after treatment. Density of corneal epithelial cells was analyzed in vivo using the Rostock Cornea Module of the Heidelberg Retina Tomograph (HRT-II). Corneas were processed using Western blot analysis and immunofluorescence examination.Schirmer's test showed a significant decrease in tear production in DE compared with controls. There was no change at 2 and 4 days after treatment with the vehicle, but a significant increase was observed at 2 and 4 days in the RvE1-treated group. The density of the superficial epithelial cells showed a significant decrease after DE compared with controls, which increased after 7 days of RvE1 treatment. Western blot analysis showed that α-smooth muscle actin and cyclooxygenase-2 (COX-2) expression were strongly upregulated after DE and decreased after 7 days of RvE1 treatment. Immunofluorescence confirmed strong positive staining of α-smooth muscle actin and COX-2 in stroma and/or in epithelia after DE, which decreased with RvE1 treatment. The percentage of infiltrating CD⁴+ T cells and CD11b+ cells decreased after RvE1 treatment when compared with DE.RvE1 promotes tear production, corneal epithelial integrity, and a decrease in inflammatory inducible COX-2. In the stroma, RvE1 inhibits keratocyte transformation to myofibroblasts and lowers the number of monocytes/macrophages in this DE mouse model. These results suggest that RvE1 and similar resolvin analogs have therapeutic potential in the treatment of DE." @default.
• W1992307218 created "2016-06-24" @default.
• W1992307218 creator A5007269557 @default.
• W1992307218 creator A5008518278 @default.
• W1992307218 creator A5015926296 @default.
• W1992307218 creator A5031315906 @default.
• W1992307218 creator A5062196910 @default.
• W1992307218 date "2010-10-01" @default.
• W1992307218 modified "2023-09-23" @default.
• W1992307218 title "Resolvin E1 Improves Tear Production and Decreases Inflammation in a Dry Eye Mouse Model" @default.
• W1992307218 cites W159554933 @default.
• W1992307218 cites W1739691545 @default.
• W1992307218 cites W1857016869 @default.
• W1992307218 cites W1948124060 @default.
• W1992307218 cites W1968528693 @default.
• W1992307218 cites W1975366833 @default.
• W1992307218 cites W1979004719 @default.
• W1992307218 cites W1983711728 @default.
• W1992307218 cites W2024921065 @default.
• W1992307218 cites W2025896394 @default.
• W1992307218 cites W2040211695 @default.
• W1992307218 cites W2042681667 @default.
• W1992307218 cites W2047848796 @default.
• W1992307218 cites W2050568435 @default.
• W1992307218 cites W2056653444 @default.
• W1992307218 cites W2057652942 @default.
• W1992307218 cites W2061167233 @default.
• W1992307218 cites W2067494913 @default.
• W1992307218 cites W2074277275 @default.
• W1992307218 cites W2078354178 @default.
• W1992307218 cites W2099020618 @default.
• W1992307218 cites W2102138771 @default.
• W1992307218 cites W2107104127 @default.
• W1992307218 cites W2124494071 @default.
• W1992307218 cites W2124600315 @default.
• W1992307218 cites W2131458900 @default.
• W1992307218 cites W2138109837 @default.
• W1992307218 cites W2138988829 @default.
• W1992307218 cites W2149876480 @default.
• W1992307218 cites W2157340973 @default.
• W1992307218 cites W2167601697 @default.
• W1992307218 cites W2184413367 @default.
• W1992307218 cites W2403337511 @default.
• W1992307218 cites W2751545921 @default.
• W1992307218 cites W4288400169 @default.
• W1992307218 doi "https://doi.org/10.1089/jop.2010.0019" @default.
• W1992307218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2956380" @default.
• W1992307218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20874497" @default.
• W1992307218 hasPublicationYear "2010" @default.
• W1992307218 type Work @default.
• W1992307218 sameAs 1992307218 @default.
• W1992307218 citedByCount "115" @default.
• W1992307218 countsByYear W19923072182012 @default.
• W1992307218 countsByYear W19923072182013 @default.
• W1992307218 countsByYear W19923072182014 @default.
• W1992307218 countsByYear W19923072182015 @default.
• W1992307218 countsByYear W19923072182016 @default.
• W1992307218 countsByYear W19923072182017 @default.
• W1992307218 countsByYear W19923072182018 @default.
• W1992307218 countsByYear W19923072182019 @default.
• W1992307218 countsByYear W19923072182020 @default.
• W1992307218 countsByYear W19923072182021 @default.
• W1992307218 countsByYear W19923072182022 @default.
• W1992307218 countsByYear W19923072182023 @default.
• W1992307218 crossrefType "journal-article" @default.
• W1992307218 hasAuthorship W1992307218A5007269557 @default.
• W1992307218 hasAuthorship W1992307218A5008518278 @default.
• W1992307218 hasAuthorship W1992307218A5015926296 @default.
• W1992307218 hasAuthorship W1992307218A5031315906 @default.
• W1992307218 hasAuthorship W1992307218A5062196910 @default.
• W1992307218 hasBestOaLocation W19923072182 @default.
• W1992307218 hasConcept C104317684 @default.
• W1992307218 hasConcept C118487528 @default.
• W1992307218 hasConcept C126322002 @default.
• W1992307218 hasConcept C142724271 @default.
• W1992307218 hasConcept C150903083 @default.
• W1992307218 hasConcept C185592680 @default.
• W1992307218 hasConcept C19038510 @default.
• W1992307218 hasConcept C207001950 @default.
• W1992307218 hasConcept C2776091944 @default.
• W1992307218 hasConcept C2776415932 @default.
• W1992307218 hasConcept C2776882836 @default.
• W1992307218 hasConcept C2776914184 @default.
• W1992307218 hasConcept C2780942790 @default.
• W1992307218 hasConcept C543025807 @default.
• W1992307218 hasConcept C55493867 @default.
• W1992307218 hasConcept C71924100 @default.
• W1992307218 hasConcept C86803240 @default.
• W1992307218 hasConceptScore W1992307218C104317684 @default.
• W1992307218 hasConceptScore W1992307218C118487528 @default.
• W1992307218 hasConceptScore W1992307218C126322002 @default.
• W1992307218 hasConceptScore W1992307218C142724271 @default.
• W1992307218 hasConceptScore W1992307218C150903083 @default.
• W1992307218 hasConceptScore W1992307218C185592680 @default.
• W1992307218 hasConceptScore W1992307218C19038510 @default.
• W1992307218 hasConceptScore W1992307218C207001950 @default.
• W1992307218 hasConceptScore W1992307218C2776091944 @default.
• W1992307218 hasConceptScore W1992307218C2776415932 @default.

• next